StemGenex Recognizes National Arthritis Awareness MonthMay 31, 2017
May is recognized each year as National Arthritis Awareness Month. According to the Arthritis Foundation, the disease impacts more than 50 million Americans, making it the number one cause of disability in the country. That means one in every five adults, 300,000 children and countless families are affected by arthritis.
One option that is receiving important attention is the use of adult stem cells as a weapon in the arsenal to address arthritis. Recently, Fiona Cunningham, Director of Community Advancement for the Arthritis Foundation South Central Region, stated “We are excited about the groundbreaking advancements in adult stem cell research leading toward new treatments and therapies for arthritis patients.”
The NIH agrees that stem cell treatments could help to further treat these types of illnesses. In a statement, they said, “One of the more perplexing questions in biomedical research is — why does the body’s protective shield against infections, the immune system, attack its own vital cells, organs and tissues? The answer to this question is central to understanding an array of autoimmune diseases, such as Rheumatoid Arthritis, Type 1 Diabetes, Systemic Lupus Erythematosus, and Sjogren’s syndrome.”
“Research on stem cells,” the statement adds, “is now providing new approaches to strategically remove the misguided immune cells and restore normal immune cells to the body.”
StemGenex Medical Group, an organization committed to helping people achieve optimum health and better quality of life through the healing benefits of their own stem cells, noted that new treatments and advances in research are giving new hope to people affected by debilitating conditions such as Rheumatoid Arthritis.
“StemGenex Medical Group provides adult stem cell therapy to potentially help those with unmet clinical needs improve their quality of life,” stated Rita Alexander, Chief Administrative Officer. “As one of those afflicted with Rheumatoid Arthritis, I found significant improvement in my condition and renewed hope through adult stem cell therapy. That was the significant motivation that lead to the start of StemGenex.”
Alexander noted, “The excellent news is that the 21st Century Cures Act, a landmark piece of legislation focused on medical innovation and medical research, was signed into law by President Obama in December of 2016. This Act provides the Food and Drug Administration (FDA) with the flexibility to accelerate how it evaluates regenerative medicine treatments, such as stem cell therapies, while maintaining its high standards of safety and efficacy.”
To find out if you are a candidate for stem cell treatment, Call (855) 742-7836 to speak with a Patient Advocate of Visit www.StemGenex.com.